Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal of Gynecologic Oncology|October 17, 2022
High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancerShu Yazaki, Yuki Kojima, Hiroshi Yoshida, et al.
Breast Cancer Research and Treatment|December 9, 2022
Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancerAkihiko Shimomura, Masayuki Yoshida, Takashi Kubo, et al.
Oncology|April 11, 2022
Poor Treatment Outcomes with Second-Line Chemotherapy in Advanced Synovial SarcomaYuki Kojima, Tatsunori Shimoi, Takuji Seo, et al.
Oncology Letters|August 18, 2020
HER3 protein expression as a risk factor for post-operative recurrence in patients with early-stage adenocarcinoma and adenosquamous carcinoma of the cervixTakaaki Mizuno, Yuki Kojima, Kan Yonemori, et al.
Oncology Letters|October 30, 2020
Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancerTakaaki Mizuno, Yuki Kojima, Kan Yonemori, et al.
Virchows Archiv : an International Journal of Pathology|September 5, 2023
Discordance in PD-L1 expression using 22C3 and SP142 assays between primary and metastatic triple-negative breast cancerJun Miyakoshi, Shu Yazaki, Tatsunori Shimoi, et al.
Frontiers in Oncology|December 13, 2021
Clinical Utility of Circulating Tumor DNA in Advanced Rare CancersHitomi Sumiyoshi Okuma, Kan Yonemori, Yuki Kojima, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 24, 2024
Folate Receptor Alpha Expression and the Tumor Immune Microenvironment in Patients with Cervical CancerShu Yazaki, Yohei Chiba, Yuki Kojima, et al.
Scientific Reports|July 3, 2023
Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapySho Watanabe, Tatsunori Shimoi, Tadaaki Nishikawa, et al.
Gynecologic Oncology Reports|December 6, 2023
Therapeutic target biomarkers of patient-derived xenograft models of gastric-type cervical adenocarcinomaYuki Kojima, Hiroshi Yoshida, Toshihiro Okuya, et al.
Pageof 6